Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Literature
1.
Bennett JM, Tuechler H, Aul C et al (2016) Dysplastic erythroid precursors in the myelodysplastic syndromes and the acute myeloid leukemias: Is there biologic significance? (how should blasts be counted?). Leuk Res 47:63–69CrossRefPubMed
2.
Arenillas L, Calvo X, Luño E, Senent L, Alonso E, Ramos F, et al. Considering Bone Marrow Blasts From Non-Erythroid Cellularity Improves The Prognostic Evaluation Of Myelodysplastic Syndromes. J Clin Oncol. (2016). [epublished ahead of print].
3.
Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood 127:2391–2405CrossRefPubMed
Metadata
Title
The importance of erythroblast enumeration in myeloid neoplasia
Authors
Amer M. Zeidan
Mina Xu
David P. Steensma
Publication date
01-02-2017
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 2/2017
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-016-2862-0

Other articles of this Issue 2/2017

Annals of Hematology 2/2017 Go to the issue

Letter to the Editor

BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib

Erratum

Erratum to: BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib

Original Article

Peripheral blood lymphocyte/monocyte ratio following completion of first-line therapy predicts early relapse in patients with diffuse large B cell lymphoma

Original Article

Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma—not otherwise specified

Original Article

Cognitive and fine motor deficits in a pediatric sickle cell disease cohort of mixed ethnic origin

Original Article

Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits